EU Chronic Cough Market, Market Segmented by Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class), by Route of Administration(Oral, Injections, Inhalation and Other Route of Administration) and by Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138189
- Pages: 200
-
Format:
Report Overview
The EU Chronic Cough market size stood at around USD $1.6 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Achronic coughis when acoughlasts longer than 8 weeks in adults or 4 weeks in children. Commoncausesinclude asthma, allergies, gastroesophageal reflux disease (GERD), or bronchitis. Less commonly, it can be a sign of a moreseverecondition, such as a heartcough or lung disease
Market Drivers
The growth of the market in the region is expected to grow owing to rising incidences of chronic cough, growing product developments to treat chronic cough. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the European chronic cough market during the forecast period
1. EU Chronic Cough Market Overview
A. Market Size
2. EU Chronic Cough Market Growth Drivers
A. Rising prevalence of diabetic neuropathy, increasing expenditure on healthcare, and the growing incidence of trauma from injury
B. Rising cases of chemotherapy-induced neuropathic pain
C. Increasing number of patients suffering from conditions such as carpal tunnel syndrome
3. EU Neuropathic Pain Management Market Segmentation
A. By Type
I. Antihistamines
II. Corticosteroids
III. Decongestants
IV. Combination Drug
V. Antibiotics
VI. Acid Blockers
VII. Other Drug Class
B. By Route of Administration
I. Oral
II. Injections
III. Inhalation
IV. Other route of administration
C. By Distribution Channel
I. Retail Pharmacies
II. Online Pharmacies
III. Hospital Pharmacies
4. EU Neuropathic Pain Management Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Novartis AG Company overview, Product & Services, Strategies & Financials
B. Bayer AG Company overview, Product & Services, Strategies & Financials
C. Glaxo Smith Kline Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
